Sanofi-aventis, the third largest pharmaceutical company in the world, is acquiring the entire issued as well as new share capital of Acambis plc at 190 pence in cash for each share aggregating to £276 million. Sanofi is acquiring Acambis through Sanofi Pasteur Holding (the parent company of its Sanofi Pasteur vaccines division). Acambis is a London Stock Exchange listed UK vaccines company, developing novel vaccines that address significant unmet medical needs or substantially improve upon current standards of care.
The details can be read here.
No comments:
Post a Comment